featured
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit With First-Line Chemotherapy Plus Cetuximab in Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Liquid biopsy detects early molecular response and predicts benefit to first-line chemotherapy plus cetuximab in metastatic colorectal cancer: PLATFORM-B study
Clin. Cancer Res 2022 Sep 08;[EPub Ahead of Print], J Vidal, MC Fernández-Rodríguez, D Casadevall, P Garcia-Alfonso, D Páez, M Guix, V Alonso, MT Cano, C Santos, G Durán, E Élez, JL Manzano, R Garcia-Carbonero, R Ferreiro-Monteagudo, F Losa, E Pineda, J Sastre, F Rivera, B Bellosillo, J Tabernero, E Aranda, R Salazar, C MontagutFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.